Jay P. Ciezki

Papers

1

Total Citations

2

H-Index

1

About

Jay P. Ciezki is a leading figure in urologic oncology, with a focused expertise in the management of prostate cancer, particularly through active surveillance and radiotherapy. His major contributions center on understanding patient-reported health-related quality-of-life (HRQOL) outcomes, a critical yet often understudied aspect of cancer care. In his influential prospective, longitudinal study, Ciezki and his team demonstrated that men on active surveillance for prostate cancer maintain favorable HRQOL, providing vital evidence that supports this less invasive management strategy. This work, presented at the Journal of Urology, has garnered attention for its patient-centered approach, helping to shift clinical practice toward more personalized, quality-of-life-conscious decision-making. With over two citations on this key paper alone, Ciezki’s research has informed both clinical guidelines and patient counseling. His achievements include advancing the integration of HRQOL metrics into standard urologic oncology outcomes, ensuring that treatment success is measured not just by disease control but by the lived experience of patients. For students and researchers, Ciezki’s work underscores the importance of marrying rigorous clinical data with the human dimensions of cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
MP58-19 PATIENT-REPORTED HEALTH RELATED QUALITY-OF-LIFE (HRQOL) OUTCOMES OF PATIENTS ON ACTIVE SURVEILLANCE: RESULTS OF A PROSPECTIVE, LONGITUDINAL, SINGLE-CENTER STUDY
2 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 17

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago